Abstract PR11: Phase 1 study of a novel PARP1/2 selective inhibitor, BGB-290

Autor:	Lusong Luo, Jason D. Lickliter, Michael Millward, Hui K Gan, Tarek Meniawy, Lai Wang, Jason Yang
Rok vydání:	2015
Předmět:	Cancer Research Oncology media_common.quotation_subject Molecular targets Library science Art Press conference media_common
Zdroj:	Molecular Cancer Therapeutics. 14:PR11-PR11
ISSN:	1538-8514 1535-7163
DOI:	10.1158/1535-7163.targ-15-pr11
Popis:	This abstract has been withheld from publication due to its inclusion in the AACR-NCI-EORTC Molecular Targets Conference 2015 Official Press Program. It will be posted online at the time of its presentation in a press conference or in a session. Citation Format: Jason Lickliter, Hui Gan, Tarek Meniawy, Jason Yang, Lai Wang, Lusong Luo, Michael Millward. Phase 1 study of a novel PARP1/2 selective inhibitor, BGB-290. [abstract]. In: Proceedings of the AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics; 2015 Nov 5-9; Boston, MA. Philadelphia (PA): AACR; Mol Cancer Ther 2015;14(12 Suppl 2):Abstract nr PR11.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::a0e4d25e74facd48c3539859010935b6 https://doi.org/10.1158/1535-7163.targ-15-pr11 Zobrazit plný text záznamu